Current pharmacological treatment of obsessive-compulsive disorder
Other Title(s)
العلاج الدوائي الحالي لاضطراب الوسواس القهري
Joint Authors
al-Tamimi, Sudad Jawad
Jamil, Nahlah Fawzi
Source
The Arab Journal of Psychiatry
Issue
Vol. 31, Issue 2 (30 Nov. 2020), pp.98-104, 7 p.
Publisher
The Arab Federation of Psychiatrists
Publication Date
2020-11-30
Country of Publication
Jordan
No. of Pages
7
Main Subjects
Abstract EN
Obsessive-Compulsive Disorder (OCD) has moved from an anxiety disorder to a new distinct group of mental disorders.
The pharmacological basis for management of OCD is now better understood, and the guidelines for use of medication have proliferated in the past few years.
This article reviews the current recommendations and the basis for the use of medication for the treatment of OCD.
American Psychological Association (APA)
al-Tamimi, Sudad Jawad& Jamil, Nahlah Fawzi. 2020. Current pharmacological treatment of obsessive-compulsive disorder. The Arab Journal of Psychiatry،Vol. 31, no. 2, pp.98-104.
https://search.emarefa.net/detail/BIM-1268291
Modern Language Association (MLA)
al-Tamimi, Sudad Jawad& Jamil, Nahlah Fawzi. Current pharmacological treatment of obsessive-compulsive disorder. The Arab Journal of Psychiatry Vol. 31, no. 2 (Nov. 2020), pp.98-104.
https://search.emarefa.net/detail/BIM-1268291
American Medical Association (AMA)
al-Tamimi, Sudad Jawad& Jamil, Nahlah Fawzi. Current pharmacological treatment of obsessive-compulsive disorder. The Arab Journal of Psychiatry. 2020. Vol. 31, no. 2, pp.98-104.
https://search.emarefa.net/detail/BIM-1268291
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 102-104
Record ID
BIM-1268291